Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)
Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-80
SponsorFudan University
About this trial
This is a clinical trial from the Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1020. The goal of this clinical trial is to confirm the therapeutic effect of Wedge resection for ground-glass opacity-featured lung cancer with a size less than 2cm and a consolidation-to-tumor ratio between 0.25 to 0.5.
Eligibility criteria
Qualifiers
Patients who sign the informed consent form and are willing to complete the study according to the plan;
Aged from 18 to 80 years old;
ECOG equals 0 or 1;
Not receiving lung cancer surgery before;
Disqualifiers
Postoperative pathologic diagnosis of adenocarcinoma in situ or minimally invasive adenocarcinoma.
CTR is not between 0.25-0.5 or nodule size greater than 2 cm;
Cannot be completely resected by wedge resection;
Invasive lung adenocarcinoma or lung malignancy other than lung adenocarcinoma diagnosed cytologically or pathologically;
Trial design
Treatments tested in this trial
- Wedge resection
Treatment groups
286 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov